Catalyst Pharmaceuticals
CPRX
#3759
Rank
HK$30.24 B
Marketcap
HK$247.09
Share price
0.00%
Change (1 day)
59.95%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: HK$30.24 Billion

As of August 2026 Catalyst Pharmaceuticals has a market cap of HK$30.24 Billion. This makes Catalyst Pharmaceuticals the world's 3759th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$30.24 B29.89%
2025HK$23.28 B17.13%
2024HK$19.88 B42.04%
2023HK$13.99 B-7.46%
2022HK$15.12 B178.18%
2021HK$5.43 B102.33%
2020HK$2.68 B-11.01%
2019HK$3.01 B95.49%
2018HK$1.54 B-50.66%
2017HK$3.13 B363.79%
2016HK$0.67 B-57.1%
2015HK$1.57 B-1.19%
2014HK$1.59 B94.53%
2013HK$0.81 B486.09%
2012HK$0.13 B-43.57%
2011HK$0.24 B65.63%
2010HK$0.14 B69.58%
2009HK$88.11 M-54.95%
2008HK$0.19 B-41.96%
2007HK$0.33 B-28.33%
2006HK$0.47 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.910 T 16,134.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.190 T 3,835.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$1.501 T 4,863.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$14.83 B-50.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$6.44 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$105.23 B 247.89%๐Ÿ‡บ๐Ÿ‡ธ USA